Saudi Arabia’s Avalon Pharma prices IPO at top of range

Saudi-based Middle East Pharmaceutical Industries Company, known as Avalon Pharma, priced its initial public offering (IPO) at the top of its range, selling the shares at 82 riyals ($21.87) each on Wednesday.

Avalon Pharma is offering six million shares, or 30 percent of its issued share capital, on the Saudi Exchange’s Main Market.

Earlier this month, the company disclosed a price range of between 78 riyals and 82 riyals a share.

Headquartered in Riyadh, Avalon Pharma’s main activities include the development, manufacturing and marketing of consumer health and beauty brands as well as generic prescription medicines.

Related Articles

Back to top button